MACM

March Altus Capital Management Portfolio holdings

AUM $16M
This Quarter Return
+15.65%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$16M
AUM Growth
+$16M
Cap. Flow
+$1.9M
Cap. Flow %
11.9%
Top 10 Hldgs %
98.74%
Holding
12
New
4
Increased
2
Reduced
3
Closed
1

Top Buys

1
EW icon
Edwards Lifesciences
EW
$1.93M
2
TSRO
TESARO, Inc.
TSRO
$1M
3
ZTS icon
Zoetis
ZTS
$827K
4
BIIB icon
Biogen
BIIB
$814K
5
DXCM icon
DexCom
DXCM
$219K

Top Sells

1
ALGN icon
Align Technology
ALGN
$1.4M
2
LLY icon
Eli Lilly
LLY
$1.08M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
$318K
4
ALXN
Alexion Pharmaceuticals Inc
ALXN
$294K

Sector Composition

1 Healthcare 87.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EW icon
1
Edwards Lifesciences
EW
$48B
$4.17M 26.11%
34,611
+16,000
+86% +$1.93M
ACAD icon
2
Acadia Pharmaceuticals
ACAD
$4.33B
$2.31M 14.47%
72,723
-10,000
-12% -$318K
PETX
3
DELISTED
Aratana Therapeutics, Inc.
PETX
$2.05M 12.79%
218,515
– –
JNJ icon
4
Johnson & Johnson
JNJ
$428B
$1.54M 9.61%
13,000
– –
DXCM icon
5
DexCom
DXCM
$29.1B
$1.25M 7.79%
14,200
+2,500
+21% +$219K
LLY icon
6
Eli Lilly
LLY
$659B
$1.07M 6.68%
13,310
-13,500
-50% -$1.08M
TSRO
7
DELISTED
TESARO, Inc.
TSRO
$1M 6.27%
+10,000
New +$1M
ZTS icon
8
Zoetis
ZTS
$67.7B
$827K 5.17%
+15,900
New +$827K
BIIB icon
9
Biogen
BIIB
$20.5B
$814K 5.09%
+2,600
New +$814K
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$760K 4.75%
6,199
-2,400
-28% -$294K
REGN icon
11
Regeneron Pharmaceuticals
REGN
$61.2B
$201K 1.26%
+500
New +$201K
ALGN icon
12
Align Technology
ALGN
$9.95B
– –
-17,319
Closed -$1.4M